MedTrace Logo

Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia

NCT04542044 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-09-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the strategy of investigators for outpatients SARS-CoV-2 moderate pneumonia management in terms of efficacy and patient safety. The investigators ultimate goal is to validate first wave management strategy in order to support the investigators future approach in the event of a second wave, and spare the hospital resources by safely keeping at home as many patients as possible.

Conditions

Interventions

OTHER

management strategy of outpatient with mild to moderate SARS-CoV-2 pneumonia

Data collected with a cohorte of SARS-CoV-2 pneumonia in an outpatient basis

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-02
Primary Completion
2020-05-05
Completion
2020-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04542044 on ClinicalTrials.gov